Bora Rawcliffe

Pfizer FCPA Settlement Emphasizes the Importance of Robust Compliance Programs for the Healthcare Industry

The healthcare industry has been under increased SEC and DOJ scrutiny lately for potential FCPA violations. What has been described as an “industry sweep,” has focused primarily on medical device and pharmaceutical companies....more

1/23/2013 - Compliance DOJ Due Diligence FCPA Foreign Official Healthcare Pfizer SEC